Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting. (Q34225057)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11311995%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11311995%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11311995%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

R L de Vrueh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11311995%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J Kuiper

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11311995%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M K Bijsterbosch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11311995%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

E A Biessen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11311995%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

T J van Berkel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11311995%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11311995%20AND%20SRC:MED&resulttype=core&format=json

Advanced Drug Delivery Reviews

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11311995%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11311995%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

251-276

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11311995%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11311995%20AND%20SRC:MED&resulttype=core&format=json

Lipoprotein receptors and cholesterol homeostasis

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Introduction to the plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Chylomicron assembly and catabolism: role of apolipoproteins and receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Regulation of plasma cholesterol by lipoprotein receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Identification of scavenger receptor SR-BI as a high density lipoprotein receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Apoproteins in association with intralipid incubations in rat and human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Metabolism of protein-free lipid emulsion models of chylomicrons in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

The effect of monostearoylglycerol on the metabolism of chylomicron-like lipid emulsions injected intravenously in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

The condensing effects of egg lecithin and cholesterol on triolein monolayers are inhibited by substitution of one saturated acyl chain in the triacylglycerol

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Effects of cholesterol content on the metabolism of protein-free emulsion models of lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Physical states of surface and core lipids in lipid emulsions and apolipoprotein binding to the emulsion surface

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Fat emulsions based on structured lipids (1,3-specific triglycerides): an investigation of the in vivo fate

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Phosphatidylcholine composition of emulsions influences triacylglycerol lipolysis and clearance from plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Effects of phospholipid composition on the metabolism of triacylglycerol, cholesteryl ester and phosphatidylcholine from lipid emulsions injected intravenously in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Cholesterol is necessary for triacylglycerol-phospholipid emulsions to mimic the metabolism of lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Effects of apoprotein E on intracellular metabolism of model triglyceride-rich particles are distinct from effects on cell particle uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Clearance from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rats and man.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Human apolipoprotein E expression in Escherichia coli: structural and functional identity of the bacterially produced protein with plasma apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Recognition of chylomicron remnants and β-migrating very-low-density lipoproteins by the remnant receptor of parenchymal liver cells is distinct from the liver α2-macroglobulin-recognition site

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Apolipoprotein E is resistant to intracellular degradation in vitro and in vivo. Evidence for retroendocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Selective liver targeting of antivirals by recombinant chylomicrons--a new therapeutic approach to hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Synthesis of the dioleoyl derivative of iododeoxyuridine and its incorporation into reconstituted high density lipoprotein particles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

In vivo gene delivery to the liver using reconstituted chylomicron remnants as a novel nonviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Involvement of specific mechanism in plasmid DNA uptake by mouse peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Characterization of plasmid DNA binding and uptake by peritoneal macrophages from class A scavenger receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Antisense oligonucleotides: a new therapeutic principle

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Pharmacokinetics of antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

In vivo fate of phosphorothioate antisense oligodeoxynucleotides: predominant uptake by scavenger receptors on endothelial liver cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Liver uptake of phosphodiester oligodeoxynucleotides is mediated by scavenger receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Preparation of conjugates of oligodeoxynucleotides and lipid structures and their interaction with low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Septic shock: pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Pathogenetic mechanisms of septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Triglyceride-rich lipoproteins prevent septic death in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Chylomicrons alter the hepatic distribution and cellular response to endotoxin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Lipoteichoic Acids: A New Class of Bacterial Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Plasma lipids and mortality: a source of error

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Changes in serum cholesterol level and mortality: a 30-year follow-up. The Finnish cohorts of the seven countries study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Low serum cholesterol and mortality. Which is the cause and which is the effect?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Increased LDL receptor mRNA expression in colon cancer is correlated with a rise in plasma cholesterol levels after curative surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

A receptor-mediated pathway for cholesterol homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Assembly of prednimustine low-density-lipoprotein complexes and their cytotoxic activity in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Low-density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

In vitro interaction of zinc(II)-phthalocyanine-containing liposomes and plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Comparative study of the incorporation of ellipticine-esters into low density lipoprotein (LDL) and selective cell uptake of drug--LDL complex via the LDL receptor pathway in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Conjugation of apolipoprotein B with liposomes and targeting to cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Effects of apolipoprotein B-100 on the metabolism of a lipid microemulsion model in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Rate and equilibrium constants for binding of apo-E HDL c (a cholesterol-induced lipoprotein) and low density lipoproteins to human fibroblasts: Evidence for multiple receptor binding of apo-E HDL c

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Metabolic behavior in rats of a nonprotein microemulsion resembling low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Synthesis of a lipophilic daunorubicin derivative and its incorporation into lipidic carriers developed for LDL receptor-mediated tumor therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Design and synthesis of novel amphiphilic dendritic galactosides for selective targeting of liposomes to the hepatic asialoglycoprotein receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Low-density lipoprotein receptor-mediated delivery of a lipophilic daunorubicin derivative to B16 tumours in mice using apolipoprotein E-enriched liposomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Reconstitution of high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Recombinant lipoproteins: implications for structure and assembly of native lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Structural models of human apolipoprotein A-I.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Production and characterization of a reconstituted high density lipoprotein for therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Structural and functional properties of full-length and truncated human proapolipoprotein AI expressed in escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Carbohydrate-Specific Receptors of the Liver

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Specific targeting of a lipophilic prodrug of iododeoxyuridine to parenchymal liver cells using lactosylated reconstituted high density lipoprotein particles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Synthesis of a lipophilic prodrug of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and its incorporation into a hepatocyte-specific lipidic carrier

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Carrier-mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to parenchymal liver cells: a novel therapeutic approach for hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Modulation of endotoxic activity of lipopolysaccharide by high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

In vivo protection against endotoxin by plasma high density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Reconstituted high-density lipoprotein reduces LPS-stimulated TNF alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Reconstituted high density lipoprotein inhibits physiologic and tumor necrosis factor alpha responses to lipopolysaccharide in rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Inhibition of VCAM-1 Expression in Endothelial Cells by Reconstituted High Density Lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Inhibition of Atherosclerosis Development in Cholesterol-Fed Human Apolipoprotein A-I–Transgenic Rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Recombinant apolipoproteins for the treatment of vascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Exogenous supply of artificial lipoproteins does not decrease susceptibility to atherosclerosis in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Recombinant apolipoprotein A-IMilano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900109-0

7 January 2021

10.1016/S0169-409X(01)00109-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11311995%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference